Veterinary Molecular Diagnostics Market Growth, Key Players, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Veterinary Molecular Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage : by Technology (PCR, Next-Generation Sequencing, Digital PCR, Microarrays); Application (Infectious Diseases, Genetic Testing, Oncology, Toxicology, Blood Typing); Animal Type (Companion Animals, Livestock, Horses, Other Animals); End-User (Veterinary Clinics, Animal Hospitals, Research Institutes, Diagnostic Laboratories); and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00040023
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150
Page Updated: Mar 2025

AI overview of Veterinary Molecular Diagnostics Market


The Veterinary Molecular Diagnostics Market is poised for significant growth, projected to reach a market size of US$ XX million by 2031, with a robust CAGR of 8.2% from 2025 to 2031. This growth is driven by increasing pet ownership and rising incidences of animal diseases, alongside technological advancements in diagnostic methods. Key segments include applications in infectious diseases, genetic testing, and oncology, catering to various animal types such as companion animals and livestock. Future trends indicate a shift towards point-of-care diagnostics and integration with veterinary telemedicine, enhancing the efficiency of veterinary services. The Veterinary Molecular Diagnostics Market report highlights opportunities in emerging markets and collaborations with research institutions, indicating a promising landscape for stakeholders.


The Veterinary Molecular Diagnostics Market is expected to register a CAGR of 8.2% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Technology (PCR, Next-Generation Sequencing, Digital PCR, Microarrays). The market is further segmented based on by Application (Infectious Diseases, Genetic Testing, Oncology, Toxicology, Blood Typing). The report is segmented based on Animal Type (Companion Animals, Livestock, Horses, Other Animals). The report is segmented based End-User (Veterinary Clinics, Animal Hospitals, Research Institutes, Diagnostic Laboratories). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.

Purpose of the Report

The report Veterinary Molecular Diagnostics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Veterinary Molecular Diagnostics Market Segmentation

Technology

  • PCR
  • Next-Generation Sequencing
  • Digital PCR
  • Microarrays

Application

  • Infectious Diseases
  • Genetic Testing
  • Oncology
  • Toxicology
  • Blood Typing

Animal Type

  • Companion Animals
  • Livestock
  • Horses
  • Other Animals

End-User

  • Veterinary Clinics
  • Animal Hospitals
  • Research Institutes
  • Diagnostic Laboratories

Customize This Report To Suit Your Requirement

You will get customization on any report - free of charge - including parts of this report, or country-level analysis, Excel Data pack, as well as avail great offers and discounts for start-ups & universities

Veterinary Molecular Diagnostics Market: Strategic Insights

veterinary-molecular-diagnostics-market
  • Get Top Key Market Trends of this report.
    This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Veterinary Molecular Diagnostics Market Growth Drivers

  • Increasing Pet Ownership: The rising trend of pet ownership worldwide, especially in emerging markets, is significantly driving the veterinary molecular diagnostics market. As pet owners become more conscious of their pets' health and seek accurate diagnoses, the demand for advanced molecular diagnostic tools, such as PCR tests, to detect diseases at early stages continues to grow.
  • Rising Animal Disease Incidences: The growing prevalence of zoonotic diseases and infections in animals is driving demand for molecular diagnostics in veterinary care. Rapid and accurate detection of diseases like Lyme disease, Brucellosis, and FIP (Feline Infectious Peritonitis) is critical to ensure effective treatment and prevent the spread of infections to humans, spurring growth in this market.
  • Technological Advancements: Continuous innovations in diagnostic technologies, including PCR (Polymerase Chain Reaction), next-generation sequencing (NGS), and digital PCR, are driving the veterinary molecular diagnostics market. These advancements provide more accurate, rapid, and cost-effective diagnostics, improving disease management and treatment for animals and thereby fueling market growth in veterinary healthcare.

Veterinary Molecular Diagnostics Market Future Trends

  • Point-of-Care Diagnostics: The increasing trend toward point-of-care (POC) diagnostics in veterinary practices is shaping the molecular diagnostics market. These portable and rapid diagnostic tools allow veterinarians to diagnose diseases like viral infections, genetic disorders, and bacterial infections quickly, leading to better treatment decisions and more efficient use of veterinary resources.
  • Integration with Veterinary Telemedicine: The rise of veterinary telemedicine has accelerated the adoption of molecular diagnostics. Remote consultations, in which diagnostic results are shared and interpreted digitally, have made it easier for veterinary professionals to assess pet health and recommend treatments, driving the market for molecular diagnostic tools that provide accurate and quick results for telemedicine platforms.
  • Increased Focus on Genetic Testing: With the growing awareness of hereditary diseases in pets, there is a rising demand for genetic testing in veterinary care. Genetic testing helps in early diagnosis, breeding management, and disease prevention, leading to a market trend toward more advanced molecular diagnostic tools focused on pet genetics and inherited conditions.

Veterinary Molecular Diagnostics Market Opportunities

  • Expanding Veterinary Services in Emerging Markets: The rising disposable income and increasing pet ownership in emerging economies such as Asia-Pacific and Latin America present a significant opportunity for the veterinary molecular diagnostics market. Expanding veterinary healthcare services in these regions will drive the demand for advanced diagnostic solutions and promote market growth.
  • Collaboration with Veterinary Research Institutions: Collaboration between veterinary diagnostic companies and research institutions offers opportunities to accelerate the development of new diagnostic tests and technologies. These partnerships can lead to the introduction of cutting-edge molecular diagnostic solutions, further driving the veterinary molecular diagnostics market.
  • Development of Breed-Specific Diagnostic Kits: The growing demand for breed-specific testing for genetic diseases and conditions opens up opportunities for the development of customized diagnostic kits. By focusing on particular breeds and their unique genetic predispositions, companies can create targeted diagnostic solutions, tapping into niche markets and expanding their product offerings

Veterinary Molecular Diagnostics Market Regional Insights

The regional trends and factors influencing the Veterinary Molecular Diagnostics Market throughout the forecast period have been thoroughly explained by the analysts at The Insight Partners. This section also discusses Veterinary Molecular Diagnostics Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

veterinary-molecular-diagnostics-market-global-geography
  • Get the Regional Specific Data for Veterinary Molecular Diagnostics Market

Veterinary Molecular Diagnostics Market Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 8.2%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Technology
  • PCR
  • Next-Generation Sequencing
  • Digital PCR
  • Microarrays
By Application
  • Infectious Diseases
  • Genetic Testing
  • Oncology
  • Toxicology
  • Blood Typing
By Animal Type
  • Companion Animals
  • Livestock
  • Horses
  • Other Animals
By End-User
  • Veterinary Clinics
  • Animal Hospitals
  • Research Institutes
  • Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • IDEXX Laboratories, Inc.
  • Zoetis Inc.
  • Thermo Fisher Scientific Inc.
  • Virbac
  • Qiagen N.V.
  • Biogal Galed Labs
  • Abaxis Inc. (now part of Zoetis)
  • Randox Laboratories
  • Neogen Corporation
  • Randox Laboratories

  • Veterinary Molecular Diagnostics Market Players Density: Understanding Its Impact on Business Dynamics

    The Veterinary Molecular Diagnostics Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

    Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

    Major Companies operating in the Veterinary Molecular Diagnostics Market are:

    1. IDEXX Laboratories, Inc.
    2. Zoetis Inc.
    3. Thermo Fisher Scientific Inc.
    4. Virbac
    5. Qiagen N.V.
    6. Biogal Galed Labs

    Disclaimer: The companies listed above are not ranked in any particular order.


    veterinary-molecular-diagnostics-market-cagr

    • Get the Veterinary Molecular Diagnostics Market top key players overview

    Key Selling Points

    • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Veterinary Molecular Diagnostics Market, providing a holistic landscape.
    • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
    • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
    • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

    The research report on the Veterinary Molecular Diagnostics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.


    Frequently Asked Questions

    1
    What are the major drivers of the veterinary molecular diagnostics market?
    Key drivers include increasing pet ownership, rising animal disease incidences, and technological advancements in diagnostic tools, particularly PCR and NGS, enabling accurate and rapid disease detection in animals.
    2
    Which region is expected to see the highest growth in the veterinary molecular diagnostics market?
    The Asia-Pacific region is expected to see the highest growth, driven by rising pet ownership, increasing disposable income, and improving veterinary healthcare infrastructure.
    3
    What are the most commonly used diagnostic technologies in veterinary care?
    Commonly used technologies include Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), digital PCR, and microarrays, which are used for diagnosing infections, genetic disorders, and cancer in animals.
    4
    What opportunities exist in the veterinary molecular diagnostics market?
    Opportunities include expanding services in emerging markets, collaborating with research institutions to develop innovative tests, and creating breed-specific diagnostic kits that address the genetic health concerns of particular pet breeds.
    5
    What trends are influencing the veterinary molecular diagnostics market?
    Key trends include the shift toward point-of-care diagnostics, integration with veterinary telemedicine, and an increased focus on genetic testing, leading to more personalized and accurate veterinary care.
    6
    How many number of pages is the standard report?
    Approximately 150-200 word file pages is the standard report
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients

    • IDEXX Laboratories, Inc.

    • Zoetis Inc.

    • Thermo Fisher Scientific Inc.

    • Virbac

    • Qiagen N.V.

    • Biogal Galed Labs

    • Abaxis Inc. (now part of Zoetis)

    • Randox Laboratories

    • Neogen Corporation

    • Randox Laboratories

    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo